St Pharm Co (XKRX:237690) Interest Expense : ₩-23,102 Mil (TTM As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is St Pharm Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. St Pharm Co's interest expense for the three months ended in Dec. 2024 was ₩ -23,102 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-23,102 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. St Pharm Co's Operating Income for the three months ended in Dec. 2024 was ₩ 22,776 Mil. St Pharm Co's Interest Expense for the three months ended in Dec. 2024 was ₩ -23,102 Mil. St Pharm Co's Interest Coverage for the quarter that ended in Dec. 2024 was 0.99. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

St Pharm Co Interest Expense Historical Data

The historical data trend for St Pharm Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

St Pharm Co Interest Expense Chart

St Pharm Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-644.58

-5,157.42

-2,867.84

-6,105.61

-7,738.49

St Pharm Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-1,926.70	-	-	-	-23,102.38

St Pharm Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-23,102 Mil.

St Pharm Co (XKRX:237690) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

St Pharm Co's Interest Expense for the three months ended in Dec. 2024 was ₩-23,102 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₩22,776 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₩44,767 Mil.

St Pharm Co's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	22776.105	/	-23102.384
	=	0.99

The higher the ratio, the stronger the company's financial strength is.

St Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » St Pharm Co Ltd (XKRX:237690) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

Teheran Road 78, Gangnam-gu, 7F MSA Building, Daechi-dong, Seoul, KOR, 891-43

Website

http://www.stpharm.co.kr

St Pharm Co Ltd offers custom manufacturing services of Active pharmaceutical ingredients and their intermediates for their use in pharmaceutical development and be compliant to cGMP, requirements. The firm's business areas include commercial manufacturing of new drug development, manufacturing of generic active pharmaceutical ingredients, fine chemical's business and development of oligonucleotide therapeutics. The company's products comprise small molecule active pharmaceutical ingredients, Anti-cancer, Anti- coagulant active pharmaceutical ingredients, etc.

St Pharm Co Headlines

No Headlines